Tuesday, September 13, 2022

Tianjin Yibeihong Biopharma Receives Patent For TOBACCO-FLAVORED GUM

 

There were 2,215 press releases posted in the last 24 hours and 241,424 in the last 365 days.

This is article preview. The link is valid for one day. Back to Dashboard

Tianjin Yibeihong Biopharma Receives Patent For TOBACCO-FLAVORED GUM

Patent CN 102125157A

Patent CN 102125157A

Tianjin Yibeihong Biopharma at Biopharma Development & Production Shanghai, China.

Tianjin Yibeihong Biopharma at Biopharma Development & Production Shanghai, China.

Attacking Biological Mechanisms of Aging to Extend Healthspan

Attacking Biological Mechanisms of Aging to Extend Healthspan.

Our key technology is based on a surprising new discovery that helps people quit smoking.”
— said Dr. Yu Hongjian, PhD of Tianjin Yibeihong Biopharma.
HEPING, TIANJIN, CHINA, September 13, 2022/EINPresswire.com/ -- Tianjin Yibeihong Biopharma, a clinical stage biopharmaceutical company has received patent CN 102125157A on July 20, 2011. This patent is a method of use patent for – Chewing gum with cigarette taste and preparation method thereof. According to the patent Abstract: The chewing gum with the cigarette taste has the characteristics of the chewing gum and also has the taste similar to cigarette, so that people who want to quit smoking do not generate great pain at the early smoke-quitting stage and influence of harmful substances of the cigarette on a human body can be reduced. The chewing gum with the cigarette taste is convenient to carry and can be taken without being influenced by time and places.

The new gum tastes just like a menthol cigarette and has 0% nicotine. The tobacco-flavored gum will sell for $1 per pack and, while it mimics the taste of a menthol cigarette, it’s completely NICOTINE FREE. The chewing gum with the cigarette taste may be used to complement current treatments for nicotine addiction, including withdrawal and relapse. As the molecular mechanisms of action of traditional Chinese herbal medicines are elucidated, further advances in their use for the treatment of nicotine addiction are as effective as most of the over-the-counter smoking cessation drugs approved, by the FDA, that you can buy, without a prescription.

The FDA has approved two smoking cessation products that do not contain nicotine. They are Chantix (varenicline tartrate) and Zyban (buproprion hydrochloride). Both are available in tablet form and by prescription only. According to federal law, tobacco manufacturers cannot market cigarettes with “characterizing flavors,” except for menthol- or tobacco-flavored cigarettes.

In a statement from Inventor Dr. Yu Hongjian, PhD, CEO, President and co-founder of Tianjin Yibeihong Biopharma on the origin of the invention and R&D activities in China. "Our key technology is based on a surprising new discovery that helps people quit smoking. With these patents and proof of concept studies, we continue to secure our corporate position and development strategy to develop new therapies for smoking cessation," he said. In addition, Dr. Hongjian, says the chewable tobacco-flavored gum is “healthy” and high in compounds that may benefit the heart and increase longevity.

The information was submitted for publication at 4:58 pm CET, on September 13, 2022.

The following patent files are available for download:

https://patentimages.storage.googleapis.com/6f/d1/9c/5cda236a81d1e4/CN102125157A.pdf

For further enquiries, please contact:

Dr. Yu Hongjian, PhD
Tianjin Yibeihong Biopharma
+852 5423 0933
tianjinyibeihongbiopharma@googlegroups.com

The FDA Plans To Ban Menthol Cigarettes: What You Need To Know - Steve Forbes | What's Ahead | Forbes


No comments:

Post a Comment

Tasty Carrot Corporation Launches “Eco Carrot” The World's First Caffeinated Carrot Juice

  World Media Directory  ·    RSS  ·    Email Newsletters There were 1,332 press releases posted in the last 24 hours and 319,424 in the las...